Cytori Therapeutics reported $-5094000 in Operating Profit for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Baxter International BAX:US USD -2799000000 3.15B
Cytori Therapeutics CYTX:US USD -5094000 26K
Dr.Reddys Laboratories DRRD:IN INR 15.9B 9.5B
Infinity Pharmaceuticals INFI:US USD -10881000 1.14M
Mirati Therapeutics MRTX:US USD -186443000 9.24M
Northwest Biotherapeutics NWBO:US USD -16074000 5.14M
Starpharma Holdings Ltd SPL:AU AUD -7705000 744K
Sun Pharmaceuticals SUNP:IN INR 25.88B 4.37B
Teva Pharmaceutical TEVA:IT USD 419M 1.37B